Treace Medical Concepts, Inc. (TMCI) Stock
TMCI Key Statistics
About Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
CEO: John T. Treace. Company website
TMCI — Frequently Asked Questions
What is the TMCI stock price today?
Treace Medical Concepts, Inc. (TMCI) trades at $1.97, up 28.97% on the day, as of Sep 20, 2026 15:00 UTC.
What is Treace Medical Concepts, Inc.'s market cap?
Treace Medical Concepts, Inc. has a market capitalisation of $127.46M, calculated from the live TMCI share price and shares outstanding.
What is the P/E ratio of TMCI?
TMCI has no meaningful price-to-earnings ratio: Treace Medical Concepts, Inc. lost $0.94 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Treace Medical Concepts, Inc. make?
Treace Medical Concepts, Inc. generated revenue of $212.69M over the trailing twelve months, which puts the stock at 0.60 times sales.
What is the 52-week range for TMCI?
TMCI has traded between $1.17 and $2.20 over the past 52 weeks, and the last price is 10.3% below that high.
Is Treace Medical Concepts, Inc. profitable?
No. Treace Medical Concepts, Inc. is loss-making, with a net margin of -27.74% over the trailing twelve months.
What is the analyst price target for TMCI?
Wall Street analysts rate TMCI Hold, with an average price target of $3.00, 52.0% above the current price.
What sector is Treace Medical Concepts, Inc. in?
Treace Medical Concepts, Inc. is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US .
Who is the CEO of Treace Medical Concepts, Inc.?
John T. Treace is the chief executive of Treace Medical Concepts, Inc., which employs 477 people.
Where can I track TMCI in real time?
QFI Terminal shows TMCI with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See TMCI live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open TMCI in Terminal See plans